Associations between initiating antihypertensive regimens on stage I-III colorectal cancer outcomes: A Medicare SEER cohort analysis.
Rajesh BalkrishnanRaj P DesaiAditya NarayanFabian T CamachoLucas E FlausinoRoger ChammasPublished in: Cancer medicine (2021)
Further research needs to be performed, but AH medications may present a promising, low-cost pathway to supporting CRC treatment for stage I-III cancers.